


Searching News Database: Pap test
HSMN NewsFeed - 25 Apr 2018
FDA Approval of ThinPrep(R) Integrated Imager Expands Automated Imaging for Pap Testing to More Labs
FDA Approval of ThinPrep(R) Integrated Imager Expands Automated Imaging for Pap Testing to More Labs
HSMN NewsFeed - 6 Sep 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
HSMN NewsFeed - 24 Apr 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
HSMN NewsFeed - 16 Oct 2012
Hologic Announces FDA Approval of APTIMA HPV 16 18/45 Genotype Assay for Use on the TIGRIS System
Hologic Announces FDA Approval of APTIMA HPV 16 18/45 Genotype Assay for Use on the TIGRIS System
HSMN NewsFeed - 18 Jul 2012
Guided Therapeutics Notified of CE Mark Approval for LuViva(R) Advanced Cervical Scan
Guided Therapeutics Notified of CE Mark Approval for LuViva(R) Advanced Cervical Scan
HSMN NewsFeed - 31 Oct 2011
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
HSMN NewsFeed - 19 Jul 2011
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
HSMN NewsFeed - 2 Dec 2010
FDA Accepts Guided Therapeutics' Non-Invasive Cervical Cancer Scanner PMA Application for Review
FDA Accepts Guided Therapeutics' Non-Invasive Cervical Cancer Scanner PMA Application for Review
HSMN NewsFeed - 27 Sep 2010
Guided Therapeutics Files Premarket Approval Application for Non-Invasive Cervical Cancer Scanner with FDA
Guided Therapeutics Files Premarket Approval Application for Non-Invasive Cervical Cancer Scanner with FDA
HSMN NewsFeed - 17 Feb 2010
In Phase III Data Merck's GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
In Phase III Data Merck's GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
HSMN NewsFeed - 21 Oct 2009
CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women
CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women
HSMN NewsFeed - 10 Feb 2009
Guided Therapeutics, Inc. Reports Preliminary Findings from FDA Pivotal Clinical Trial
Guided Therapeutics, Inc. Reports Preliminary Findings from FDA Pivotal Clinical Trial
HSMN NewsFeed - 26 Jan 2009
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
HSMN NewsFeed - 30 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
HSMN NewsFeed - 28 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
HSMN NewsFeed - 4 Nov 2007
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
HSMN NewsFeed - 30 Oct 2007
New Painless Test for Cervical Cancer Could Provide Access to Better Healthcare for Women Worldwide
New Painless Test for Cervical Cancer Could Provide Access to Better Healthcare for Women Worldwide
HSMN NewsFeed - 5 Sep 2007
NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
HSMN NewsFeed - 11 Jun 2007
Intelect Medical Announces $7 Million Series B Investment from Boston Scientific and Greatbatch
Intelect Medical Announces $7 Million Series B Investment from Boston Scientific and Greatbatch
HSMN NewsFeed - 9 May 2007
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 22 Mar 2007
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 21 Mar 2007
Diamics Receives FDA Clearance for Revolutionary New Cervical Sample Collection System
Diamics Receives FDA Clearance for Revolutionary New Cervical Sample Collection System
HSMN NewsFeed - 30 Jan 2007
SpectRx, Inc. Holds Pre-PMA Meetings with FDA on Painless Cervical Cancer Test
SpectRx, Inc. Holds Pre-PMA Meetings with FDA on Painless Cervical Cancer Test
HSMN NewsFeed - 14 Nov 2006
Daryl J. Faulkner Appointed Chief Executive Officer and Director of Digene
Daryl J. Faulkner Appointed Chief Executive Officer and Director of Digene
HSMN NewsFeed - 27 Oct 2006
James Godsey, Ph.D., to Join Digene as Senior Vice President Research and Development
James Godsey, Ph.D., to Join Digene as Senior Vice President Research and Development
HSMN NewsFeed - 28 Sep 2006
California to Require Insurers to Cover HPV Testing in Cervical Cancer Screening
California to Require Insurers to Cover HPV Testing in Cervical Cancer Screening
HSMN NewsFeed - 24 Jul 2006
CytoCore, Inc. Announces New Cancer Screening and Treatment System On The Horizon
CytoCore, Inc. Announces New Cancer Screening and Treatment System On The Horizon
HSMN NewsFeed - 15 May 2006
New Study Reports on Improved Disease Detection with the ThinPrep(R) Imaging System
New Study Reports on Improved Disease Detection with the ThinPrep(R) Imaging System
Additional items found! 76
Members Archive contains
76 additional stories matching:
Pap test
(Password required)
Pap test
(Password required)
